Abstract

BackgroundOsteoarthritis (OA) is one of the most prevalent joint disease, and there are still no effective therapeutic agents or clinical methods for the cure of this disease to date. The degradation of cartilage extracellular matrix (ECM) is a major cause of OA.MethodIL-1β was used to induce chondrogenic degradation. Q-PCR and Western blotting were used to detect mRNA and protein level, respectively. ELISA was used to detect the secreted TNF-α and IL-6 level. Immunofluorescence was used to detect the protein level of Aggrecan, Collagen II and ki67. TUNEL and flow cytometry were used to examine cell apoptosis of chondrocytes. ChIP and luciferase assay were used to study molecular gene regulation. Osteoarthritic animal model and Safranin-O staining were used to determine the in vivo OA phenotype.ResultsThe expression of ADAM8 was up-regulated in osteoarthritic chondrocytes. Knockdown of ADAM8 suppressed the OA phenotype in the in vitro OA cell model. ADAM8 regulated OA progression through the activation of EGFR/ERK/NF-κB signaling pathway. Inhibition of Notch signaling suppressed OA phenotype in the in vitro OA cell model. Notch signaling regulated the gene expression of ADAM8 directly via Hes1. Notch1-ADAM8 positive feedback loop promoted the progression of OA in vivo.ConclusionNotch1-ADAM8 feed-back loop regulates the degradation of chondrogenic extracellular matrix and osteoarthritis progression.

Highlights

  • Osteoarthritis (OA) is one of the most prevalent joint disease, and there are still no effective therapeutic agents or clinical methods for the cure of this disease to date

  • The expression of ADAM8 was up-regulated in osteoarthritic chondrocytes To explore the gene expression of ADAM8 in osteoarthritic chondrocytes, an in vitro OA cell model was established

  • We found that the expression of matrix metalloproteinases (MMPs)-9 was stimulated by IL-1β, surprisingly, this promotion of MMP-9 can be reversed by Adv-shRNA-ADAM8 as well

Read more

Summary

Introduction

Osteoarthritis (OA) is one of the most prevalent joint disease, and there are still no effective therapeutic agents or clinical methods for the cure of this disease to date. The degradation of cartilage extracellular matrix (ECM) is a major cause of OA. Osteoarthritis (OA) is one of the most prevalent joint disease, affecting 25% of the adult population in the whole world [1]. The degeneration of cartilage are originated from the degradation of cartilage extracellular matrix (ECM), which composed of majorly type II collagen and aggrecan [5]. The degradation of chondrogenic ECM is conducted by proteases, including matrix metalloproteinases (MMPs) for degrading collagens [6], and Adamalysin with Thrombospondin Motifs (ADAMTS) for degrading aggrecans [7]. The collagenase, including MMP-1, − 9, − 13 and − 14 are found to

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call